In vitro and in vivo characterization of [ 64 Cu][Cu(elesclomol)] as a novel theranostic agent for hypoxic solid tumors.
Tengzhi LiuMaria Aanesland DahleMathilde Hirsum LystadLaure MarignolMorten KarlsenKathrine Røe RedalenPublished in: European journal of nuclear medicine and molecular imaging (2023)
Cu][Cu(ES)] is a promising theranostic agent for hypoxic solid tumors.